![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 30, 27227-27231, July 26, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
,
,
, and
§§
From the
Department of Biological Chemistry and CREST
(Core Research for Educational Science and Technology) Project, Japan
Science and Technology Corporation, Graduate School of Pharmaceutical
Sciences, Kyoto University, Kyoto 606-8501, Japan,
§ Division of Cell Biology and Neurophysiology, Department
of Neuroscience, Faculty of Medicine, Kobe University, Kobe 650-0017, Japan and Division of Neuronal Network, Department of Basic Medical
Sciences, Institute of Medical Science, University of Tokyo, Tokyo
108-8639, Japan, ¶ Pharmaceutical Research Laboratories I,
Pharmaceutical Research Division, Takeda Chemical Industries, Ltd.,
Osaka 532-8686, Japan,
Department of Transgenic Animal Science,
Graduate School of Medical Science, Kanazawa University, Kanazawa
920-8640, Japan, ** Center for Experimental Medicine,
Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan, and 
Department of Anatomy,
Shimane Medical University, Izumo 693-8501, Japan
Received for publication, May 14, 2002
| |
ABSTRACT |
|---|
|
|
|---|
The HNK-1 carbohydrate epitope, a sulfated
glucuronic acid at the non-reducing terminus of glycans, is
expressed characteristically on a series of cell adhesion molecules and
is synthesized through a key enzyme, glucuronyltransferase (GlcAT-P).
We generated mice with a targeted deletion of the GlcAT-P gene. The
GlcAT-P Glycosylation is a major post-translational protein modification,
especially for cell surface proteins, which play important roles in a
variety of cellular functions including recognition and adhesion. In
the last decade, a number of glycosyltransferase genes and related
genes have been cloned. Targeted deletion of these genes revealed the
roles of cell surface glycans in the modulation of cellular
interactions, particularly in the immune system (1, 2). We have been
interested in the roles of a neural-specific carbohydrate, the HNK-1
carbohydrate, which is expressed on glycoproteins as well as on
glycolipids and is postulated to be associated with cell adhesion,
migration, and neurite outgrowth (3-5). The epitope is a sulfated
trisaccharide, HSO3-3GlcA Targeted Disruption of the GlcAT-P Gene--
Cloning of the
genomic clones of the 129/Sv mouse GlcAT-P gene was described
previously (10). Construction of the targeting vector is schematically
represented in Fig. 1A. The neomycin resistance gene
cassette in vector pPGKneobpA (14) and diphtheria toxin A (DT-A) gene
cassette in vector pMC1DT-A (15) were used as positive and a negative
selection markers, respectively. The targeting vector was transfected
into E14-1 embryonic stem (ES) cells (16) by electroporation. Two ES
clones among 525 tested revealed the desired homologous recombination
(13C-2 and 22D-5). To generate chimeric mice, both clones were
aggregated with C57BL/6 × BDF1 8-cell-stage embryos, and the
embryos were transferred into the uteri of pseudopregnant mice. Both
clones gave rise to germline chimeras. Mice heterozygous for the
mutation were obtained by cross-breeding of the chimeras with C57BL/6
mice. The heterozygotes were further backcrossed with C57BL/6 mice for
more than eight generations, and the resulting heterozygous mutants
were interbred to obtain wild-type and homozygous littermates. The
genotypes of the mice were determined by PCR and Southern blot analysis of genomic DNA prepared from tail tissue using a 5'-external probe (Fig. 1B).
Histochemical Staining--
Mice (6 weeks old) were deeply
anesthetized by diethyl ether inhalation and then perfused with
phosphate-buffered saline followed by 4% paraformaldehyde in
phosphate-buffered saline. The mouse brains were postfixed overnight
followed by dipping into a 30% sucrose solution. For histological
analysis, the sagittal sections (10 µm thick) were prepared, and the
sections were stained with 0.5% thionine. For immunofluorescence
staining, sections were incubated with the HNK-1 antibody and then
incubated with the anti-mouse IgM antibody conjugated with FITC. These
sections were visualized and digitized with a Fluoview laser confocal
microscope system (Olympus). For double fluorescence staining, coronal
sections of 8-week-old GlcAT-P Electrophysiology--
To compare GlcAT-P Behavioral Tests--
Behavioral tests were conducted in a blind
fashion during the light phase at approximately the same time each day.
Data were calculated as means ± S.E. and analyzed by means of
one-way analysis of variance and Student's t test;
p values greater than 0.05 were taken as not significant.
The Morris water maze test (17) has been used for analysis of spatial
navigation and hippocampus-dependent memory formation of
rodents. The apparatus consisted of a circular pool (120-cm diameter,
30-cm depth) filled with water at 30 °C. A transparent platform
(10-cm diameter) was placed at a fixed location in one quadrant of the
pool, 0.5 cm below the surface of the water. Using a video tracking
system with computerized data (Target/2, Neuroscience), we analyzed the
escape latency (platform search time), path length (the distance
traveled to reach the platform), and swimming velocity for each trial.
12-15-week-old mice were trained with blocks of four trials per day
for 4 days. The water-filled multiple T-maze was used as another test
for evaluating the spatial learning of mice. The apparatus was similar to that described previously (18). The time taken to reach the goal, as
the escape latency, was recorded. 17-20-week-old mice were trained
through three trials per day for 3 days.
Generation of GlcAT-P-deficient Mice--
Mice with targeted
deletion of the GlcAT-P gene were generated using the strategy outlined
in Fig. 1A. Most of the
catalytic region of GlcAT-P, i.e. exons 4 and 5 (10), was
replaced by a PGK-neo gene. The disrupted region is essential for the
glucuronyltransferase activity (8). The homologous recombination was
confirmed by Southern blot analysis using an external 5' probe (Fig.
1B) and 3' probe (data not shown). Two lines of GlcAT-P
GlcAT-P Is Responsible for Biosynthesis of the HNK-1 Carbohydrate
on Both Glycoproteins and Glycolipids in Vivo--
Since the HNK-1
carbohydrate is expressed on both glycoproteins and glycolipids, the
effect of GlcAT-P gene disruption on the overall ability to synthesize
the HNK-1 carbohydrate in the brain was examined. As shown in Fig.
1D, the glucuronyltransferase activity of GlcAT-P GlcAT-P-deficient Mice Lack the HNK-1 Carbohydrate in the Central
Nervous System--
As shown in Fig. 1E, the GlcAT-P
Remaining HNK-1 Carbohydrate in the GlcAT-P Reduced LTP at the Schaffer Collateral-CA1 Synapses--
The HNK-1
epitope is commonly expressed on a series of cell adhesion molecules
(CAMs) such as the neural cell adhesion molecule (NCAM), L1,
telencephalin, and tenascin-R (20). These CAMs are important
constituents of the synaptic structure and play important and diverse
roles in the regulation of synaptic plasticity. Aberrations of LTP in
the hippocampal CA1 region occurred in mice deficient in NCAM and
telencephalin (21, 22). Mice lacking extracellular matrix molecule
tenascin-R were also shown to exhibit aberrant LTP in the CA1 region
(23). With this background, we analyzed LTP in the CA1 region of
GlcAT-P +/+ and Impaired Performance in Spatial Learning Tasks in
GlcAT-P-deficient Mice--
In view of the reduced LTP, two
types of spatial learning tests were carried out with 11-15-week-old
GlcAT-P +/+ and The abnormality in higher brain functions of the GlcAT-P Recently Saghatelyan et al. (29) reported that a monoclonal
antibody that recognizes the HNK-1 carbohydrate decreased perisomatic inhibitory postsynaptic currents and enhanced LTP in acute slices of
the mouse hippocampus. This inhibition of perisomatic inhibitory postsynaptic currents by the antibody was also observed in
NCAM-deficient mice but not in tenascin-R-deficient mice. The authors
suggested that tenascin-R is a carrier molecule for the HNK-1
carbohydrate involved in the regulation of perisomatic inhibition of
CA1 pyramidal neurons by GABAergic interneurons (29). In the present
study, however, we detected reduced LTP in the presence of 100 µM picrotoxin that blocks the GABAA
receptor-mediated inhibitory synaptic response, demonstrating that a
mechanism other than the reduction of GABAergic inhibition of CA1
pyramidal neurons is involved in the attenuation of LTP in GlcAT-P
In the present study, we produced mice deficient in GlcAT-P, a
glucuronyltransferase, which is involved in biosynthesis of the HNK-1
carbohydrate. The GlcAT-P
/
mice exhibited normal development of gross anatomical
features, but the adult mutant mice exhibited reduced long term
potentiation at the Schaffer collateral-CA1 synapses and a
defect in spatial memory formation. This is the first evidence that the
loss of a single non-reducing terminal carbohydrate residue attenuates brain higher functions.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1-3Gal
1-4GlcNAc (6, 7),
and the inner structure, Gal
1-4GlcNAc, is commonly found on various
glycoproteins and glycolipids. To elucidate the roles of the HNK-1
carbohydrate more clearly, we cloned two different glucuronyltransferases (GlcAT-P and
GlcAT-S)1 (8-11), which are
key enzymes in the biosynthesis of the HNK-1 carbohydrate epitope (12,
13). In this study, we generated mice with a targeted deletion of the
GlcAT-P gene and demonstrated clearly that the HNK-1 carbohydrate is in
fact required for higher functions of the brain.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
brains were prepared and incubated
with biotinylated Wisteria floribunda agglutinin (WFA) and
the HNK-1 antibody in 5% fetal calf serum. Then reactivity was
visualized with rhodamine-avidin and a fluorescein
isothiocyanate-conjugated secondary antibody followed by
examination by laser confocal microscopy.
/
and +/+ mice,
most experiments were performed in a blind fashion, and the results
were essentially identical to those of non-blind experiments; so all
the data were pooled. 11-20-week-old GlcAT-P
/
and +/+ mice were
decapitated under deep halothane anesthesia. Hippocampal slices (400 µm thick) were prepared with a vibratome slicer and placed in a
holding chamber for at least 1 h. A single slice was then
transferred to the recording chamber and submerged beneath a
continuously perfusing medium that had been saturated with 95%
O2, 5%CO2. The medium comprised 119 mM NaCl, 2.5 mM KCl, 1.3 mM
MgSO4, 2.5 mM CaCl2, 1.0 mM NaH2PO4, 26.2 mM
NaHCO3, and 11 mM glucose. All perfusing
solutions contained 100 µM picrotoxin to block
GABAA receptor-mediated inhibitory synaptic responses.
Field potential recordings were made with a glass electrode (3 M NaCl) placed in the stratum radiatum. An Axopatch-1D
amplifier was used, and the signal was filtered at 1 kHz and digitized
at 10 kHz. To evoke synaptic responses, a bipolar tungsten stimulating
electrode was placed in the stratum radiatum, and Schaffer
collateral/commissural fibers were stimulated at 0.1 Hz. The ratio of
excitatory postsynaptic potential (EPSP)/fiber volley amplitude
(input-output relationship) of basal synaptic responses was measured in
the presence of a low concentration of
6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) (1 µM) to
partially block AMPA receptors. This enables more accurate measurement
of input-output relationships since the amplitude of EPSPs is usually
much greater than that of fiber volleys. Furthermore, the use of a low
concentration of CNQX reduces the non-linear summation of field EPSPs,
especially when strong stimulus strengths are used. All experiments
were performed at 25 °C. The data are expressed as means ± S.E. Student's t test was used to determine whether or not
there was a significant difference (p < 0.05) in the
mean between two sets of data.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
mice were generated from two independent ES clones. They gave
essentially the same results in all experiments described below.
Genotyping of 207 progeny from F1 heterozygous intercrosses suggested
that GlcAT-P
/
mice exhibit normal embryonic development. GlcAT-P
/
mice appeared to be normal, and there was no significant
difference in body weight or brain size between GlcAT-P
/
and +/+
mice up to 20 weeks after birth. Northern blot analysis of total RNA from 10-week-old mouse brains revealed that the expression of GlcAT-P
mRNA was completely abolished in GlcAT-P
/
mice (Fig. 1C). In GlcAT-P +/
mice, GlcAT-P mRNA was reduced
by ~50%. The same blot probed with the cDNA of GlcAT-S, which is
the second glucuronyltransferase involved in the biosynthesis of the
HNK-1 carbohydrate (9), indicated that the expression level of GlcAT-S mRNA in GlcAT-P +/
and
/
mice remained as low as that in
GlcAT-P +/+ mice (Fig. 1C).

View larger version (33K):
[in a new window]
Fig. 1.
Generation and analysis of GlcAT-P
/
mice. A, schematic diagram of the targeting construct. The
primers used for the screening of ES cell clones and mice are indicated
by arrows and arrowheads, respectively. The
probes used for Southern blot analysis of ES cells and mice are also
shown. B, Southern blot analysis. Genomic DNAs isolated from
mouse tail tissue from GlcAT-P +/+, +/
, and
/
littermates were
digested with the combination of ScaI and XhoI
and then hybridized with the 32P-labeled 5' probe shown in
A. Two independent lines of GlcAT-P
/
mice were
analyzed. C, Northern blot analysis. The total RNAs were
extracted from the whole brains of 10-week-old littermates and probed
with GlcAT-P or GlcAT-S cDNA according to the procedure described
previously (8). Arrowheads indicate the specific signals.
D, glucuronyltransferase activity. The Nonidet P-40 extract
was prepared from the whole brains of 10-week-old littermates as
described previously (13) and was used as the enzyme source. The
radioactivity of [14C]GlcA incorporated into
asialoorosomucoid (ASOR) and paragloboside was measured.
E, Western and lectin blot analyses. The membrane proteins
were prepared from whole brains of 10-week-old littermates. Protein
bands were stained with the HNK-1 antibody (left panel) or
various biotinylated lectins (right panel). mAb, monoclonal
antibody; MAM, M. amurensis mitogen; SSA, S. sieboldiana agglutinin; RCA, R. communis
agglutinin.
/
mice
toward the glycolipid acceptor (paragloboside) disappeared almost
completely as did the activity toward the glycoprotein acceptor
(asialoorosomucoid) in 10-week-old mice. The glucuronyltransferase activity in GlcAT-P +/
mice was reduced to about half of that in the
GlcAT-P +/+ mice for both acceptor substrates. Thus, GlcAT-P is the
most predominant glucuronyltransferase responsible for the biosynthesis
of the HNK-1 carbohydrate, and the contribution of GlcAT-S to the HNK-1
carbohydrate biosynthesis is marginal at this age.
/
mice almost completely lost the HNK-1 carbohydrate as revealed on
Western blot analysis. Several protein bands corresponding to over 100 kDa detected for GlcAT-P +/+ and +/
mice had disappeared in GlcAT-P
/
mice. The intensity of several protein bands in GlcAT-P +/
mice
decreased to about half of that in GlcAT-P +/+ mice. Similarly
immunohistochemical staining of 6-week-old mouse brains with the HNK-1
antibody revealed high levels of HNK-1 carbohydrate expression widely
in the GlcAT-P +/+ mice brains including the cerebral cortex,
hippocampus, and cerebellum (Fig. 2,
A-C). In contrast, the immunoreactivity of the HNK-1
carbohydrate in the GlcAT-P
/
mice was reduced to almost
negligible levels in all regions of the nervous system (Fig. 2,
D-F). These findings clearly indicated that GlcAT-P is the
principal enzyme responsible for the biosynthesis of the HNK-1 carbohydrate in the mature brain. There is at least the possibility that the lack of glucuronic acid at the terminus of glycans has an overall effect on the glycan structures in the brain since lectin
blot analysis with the MAM (Maackia amurensis
mitogen), SSA (Sambucus sieboldiana agglutinin), and
RCA (Ricinus communis agglutinin) lectins, which
specifically recognize the terminal structures of glycans,
i.e. Sia
2-3Gal, Sia
2-6Gal, and
-Gal, respectively, exhibited almost indistinguishable profiles in
wild-type and mutant mice (Fig. 1E). In GlcAT-P
/
mice,
non-reducing terminal galactose is presumably substituted by sialic
acid, resulting in a common terminal disaccharide, Sia-Gal.

View larger version (48K):
[in a new window]
Fig. 2.
A-F, immunohistochemical analysis of
expression of the HNK-1 carbohydrate in mouse brain. Sagittal brain
sections from 6-week-old wild-type (+/+, A-C) and
GlcAT-P-deficient (
/
, D-F) mice were immunostained with
the HNK-1 antibody. The HNK-1 carbohydrate was markedly diminished in
the cerebral cortex (A and D), hippocampus
(B and E), and cerebellum (C and
F) of GlcAT-P
/
mice. A small amount of remaining HNK-1
carbohydrate was also detected in the cerebral cortex and hippocampus
of GlcAT-P
/
mice (arrowheads in D and
E). G-L, the remaining HNK-1 immunoreactivity in
perineuronal nets of GlcAT-P (
/
) mice. Coronal sections of the
cerebral cortex of adult GlcAT-P
/
mice were stained doubly with
the HNK-1 antibody (G and J) and biotinylated WFA
(H and K). Equivalent subpopulations of cortical
neurons were stained with the HNK-1 antibody and WFA lectin
(I and L). Images of magnified regions are also
shown (J-L). Scale bars, 100 µm.
/
Mice--
In
GlcAT-P
/
mice, the HNK-1 carbohydrate disappeared almost
completely as described above. However, further studies revealed that a
trace of HNK-1 immunoreactivity remained on the surfaces of soma and
proximal dendrites of a subset of neurons in some limited regions (Fig.
2, D and E, arrowheads). Some parts of
interneurons were likely to be HNK-1-positive in the cerebral cortex,
and such remaining immunoreactivity was not so significant up to 2 weeks after birth but seemed to increase gradually thereafter. These signal patterns and morphological features imply that the remaining HNK-1 carbohydrate in the GlcAT-P
/
mice corresponded to the perineuronal nets, which are known to comprise a lattice-like accumulation of the extracellular matrix on an unidentified subset of
neurons (19). This was confirmed by double fluorescence staining of
adult GlcAT-P
/
mice with the HNK-1 antibody and an
N-acetylgalactosamine-binding lectin, WFA, a well known
marker of perineuronal nets (19). In the cerebral cortex, both signals
were detected in a restricted population of cortical neurons that were
observed mainly in layers III-V (Fig. 2, G-L), although
not all of the WFA-positive neurons were immunoreactive for the HNK-1
antibody (Fig. 2, I and L). These results
revealed that the HNK-1 carbohydrate expressed in the perineuronal net
structure was synthesized by an enzyme(s) other than GlcAT-P,
presumably GlcAT-S.
/
mice to examine the effect of HNK-1 carbohydrate
deficiency on synaptic plasticity (Fig.
3). EPSPs were evoked by stimulating
afferent fibers in the stratum radiatum of the CA1 region using the
extracellular field potential recording technique. High frequency
stimulation of afferent fibers (100 Hz for 1 s) gave rise to LTP
of excitatory synaptic transmission in the GlcAT-P +/+ mice (161.7 ± 7.3% of baseline, n = 14), while the magnitude of
LTP in the GlcAT-P
/
mice was significantly lower (131.9 ± 8.4% of baseline, n = 14; p < 0.02, t test) than that in the GlcAT-P +/+ mice (Fig. 3,
A and B). In contrast, the initial potentiation
after tetanus and the depolarization during tetanic stimulation were
similar in magnitude to those in GlcAT-P +/+ mice (data not shown). The
input-output relationship of AMPA receptor-mediated synaptic responses
in the CA1 region was not significantly different between GlcAT-P +/+ and
/
mice (Fig. 3C), suggesting that basal synaptic
transmission in GlcAT-P
/
mice is normal. We then examined three
forms of presynaptic short term plasticity in the presence of
D-(
)-2-amino-5-phosphonovaleric acid (D-APV),
which blocks any N-methyl-D-aspartate
receptor-dependent postsynaptic modification (Fig. 3,
D-F). The magnitude of post-tetanic potentiation induced by
tetanic stimulation (100 Hz for 1s) (Fig. 3D), the
paired-pulse facilitation induced by a pair of afferent fiber stimuli
at 50-, 100-, or 200-ms intervals (Fig. 3E), and the
synaptic responses to repetitive afferent fiber stimulation (5 Hz for 3 min) (Fig. 3F) were indistinguishable between GlcAT-P +/+
and
/
mice. These results indicated that the presynaptic function
is intact in GlcAT-P
/
mice and suggested that presynaptic changes are not involved in the impairment of LTP in GlcAT-P
/
mice.

View larger version (20K):
[in a new window]
Fig. 3.
A-C, LTP, but not basal synaptic
transmission, is impaired in GlcAT-P
/
mice. A, the
averaged time course of LTP in GlcAT-P +/+ (open circles,
n = 14) and
/
(closed circles,
n = 14) mice. Initial EPSP slopes were normalized in
each experiment to the mean slope value during the control
period (
30-0 min). A train of high frequency stimuli (100 Hz for 1s)
was applied at time 0. Sample traces of field EPSPs (average of 10 consecutive responses) recorded at the times indicated by the
numbers are shown in the inset. B, the
summary of LTP calculated as the percent increase in the mean EPSP
slope from 50 to 60 min after high frequency stimulation compared with
the mean EPSP slope during the control period (
30-0 min). LTP in
GlcAT-P
/
mice (closed bar) was significantly lower than
that in GlcAT-P +/+ mice (open bar) (p < 0.02, t test). C, the input-output relationship
of GlcAT-P
/
(closed circles) and +/+ (open
circles) mice. 25 µM D-APV was present
to block N-methyl-D-aspartate receptor-mediated
synaptic responses. A low concentration of CNQX (1 µM)
was also present. The data were first sorted by the range of
fiber volley amplitudes, and then EPSP amplitudes were averaged within
each range. Sample traces with various stimulus strengths are shown in
the inset. D-F, the impairment of LTP in GlcAT-P
/
mice is not mediated by the changes in presynaptic release
mechanisms. Analysis of the presynaptic short term plasticity in
GlcAT-P +/+ (open circles) and
/
(closed
circles) mice was performed in the presence of 50 µM
D-APV. D, post-tetanic potentiation recorded in
GlcAT-P +/+ (n = 9) and
/
(n = 12)
mice. A train of high frequency stimuli (100 Hz for 1s) was delivered
at time 0. E, paired-pulse facilitation in GlcAT-P +/+
(n = 13) and
/
(n = 13) mice. The
ordinate indicates the ratio of the second field EPSP slope
to the first field EPSP slope. With any interstimulus interval (50, 100, 200 ms), no significant difference was observed between the two
genotypes. F, responses to prolonged low frequency
stimulation (5 Hz for 3min) in GlcAT-P +/+ (n = 12) and
/
(n = 13) mice. amp.,
amplitude.
/
mice (Fig. 4). In
the Morris water maze test, the time taken to reach the hidden platform
(escape latency) was significantly longer for the GlcAT-P
/
mice
than for the GlcAT-P +/+ mice during 4 days of training (Fig.
4A), although the swimming speed in the task was not
significantly different between GlcAT-P +/+ and
/
mice (data not
shown). In the water-filled multiple T-maze task, the GlcAT-P
/
mice showed increased escape latencies to the goal arm compared with
the GlcAT-P +/+ mice, most significantly on day 2 during 3 days of
training (Fig. 4B). These results suggest that the
differences in performance of GlcAT-P
/
mice in the spatial
learning tasks were related to impaired spatial learning, not to
decreased motor activity.

View larger version (16K):
[in a new window]
Fig. 4.
Impaired spatial learning in GlcAT-P
/
mice. GlcAT-P +/+ (n = 17, open
circles) and
/
(n = 18, closed
circles) mice were tested with spatial learning tasks.
A, mice were trained in a Morris water maze for 4 consecutive days. Learning performance is expressed as the mean escape
latency of four trials per day. GlcAT-P
/
mice showed a
significantly longer escape latency than GlcAT-P +/+ mice
(p < 0.05, one-way analysis of variance
(ANOVA)). B, learning performance in a
water-filled multiple T-maze. Mice were given one session of three
trials per day for 3 consecutive days. The mean escape latency on
training day 2 is significantly different between the two genotypes
(p < 0.05, t test).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
mice, such as reduced LTP at the Schaffer collateral-CA1 synapses and
defect in spatial memory formation, was similar to those in NCAM-deficient mice (21, 24), suggesting that the HNK-1 carbohydrate may function through modulation of the functions of CAMs. Besides NCAM,
CAMs bearing the HNK-1 carbohydrate, such as telencephalin and
tenascin-R, have also been shown to play important roles in the
induction and expression of LTP (22, 23). The detailed molecular
mechanisms by which the HNK-1 carbohydrate modulates the functions of
CAMs are not clear at the moment. However, it should be noted that the
HNK-1 carbohydrate on NCAM and L1 was shown to negatively regulate
their homophilic binding
activity.2 The HNK-1
carbohydrate may weaken the homophilic interaction of CAMs expressed on
the synapses and facilitate synaptic plasticity. It should be noted
that only a subpopulation of CAMs express the HNK-1 carbohydrate and
that the expression is independently regulated from the biosynthesis of
CAMs, indicating that the HNK-1 carbohydrate is the characteristic
functional component in vivo as a fine tuner that regulates
synaptic plasticity or other brain functions. Alternatively the HNK-1
carbohydrate itself may be involved in LTP via interaction with binding
proteins (receptors) on the cell surface or in the cell matrix. Several
HNK-1 carbohydrate-binding proteins have been identified, such as
laminin, selectins, SBP-1, and brevican (25-28). However, the
association of these receptors or binding proteins with LTP has not
been proved.
/
mice.
/
mice exhibited gross defects in
functions of the nervous system such as LTP in the CA1 region and
hippocampus-dependent spatial learning. This is the first study to demonstrate the involvement of a carbohydrate, notably of only
a single non-reducing terminal carbohydrate residue, in higher ordered
brain functions including learning and memory.
| |
FOOTNOTES |
|---|
* This work was supported in part by Grants-in-aid for Scientific Research B-12470497 (to T. K.), A-12308043 (to T. M.), and C-13680688 (to S. O.) from the Japan Society for the Promotion of Sciences and Grants-in-aid for Scientific Research on Priority Areas A-12053251 (to T. M.) and A-12033204 (to S. O.), and Special Coordination Funds for Promoting Science and Technology (to T. M.) from the Ministry of Education, Culture, Sports and Technology.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§§ To whom correspondence should be addressed: Dept. of Biological Chemistry, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan. Tel.: 81-75-753-4572; Fax: 81-75-753-4605; E-mail: kawasaki@pharmsun.pharm.kyoto-u.ac.jp.
Published, JBC Papers in Press, May 24, 2002, DOI 10.1074/jbc.C200296200
2 K. Ohtsubo, S. Oka, A. Nakamura, Y. Mitsumoto, S. Yamamoto, K. Ono, J. Lütjohann, M. Schachner, U. Rutishauser, and T. Kawasaki, manuscript in preparation.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
GlcAT, glucuronyltransferase;
GlcA, glucuronic acid;
CAM, cell adhesion
molecule;
NCAM, neural cell adhesion molecule;
EPSP, excitatory
postsynaptic potential;
LTP, long term potentiation;
WFA, W.
floribunda agglutinin;
DT-A, diphtheria toxin A;
ES, embryonic
stem;
GABA,
-aminobutyric acid;
GABAA, GABA, type A;
CNQX, 6-cyano-7-nitroquinoxaline-2,3-dione;
AMPA,
-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid;
D-APV, D-(
)-2-amino-5-phosphonovaleric
acid.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Hennet, T.,
Chui, D.,
Paulson, J. C.,
and Marth, J. D.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
4504-4509 |
| 2. | Demetriou, M., Granovsky, M., Quaggin, S., and Dennis, J. W. (2001) Nature 409, 733-739[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Künemund, V.,
Jungalwala, F. B.,
Fischer, G.,
Chou, D. K.,
Keilhauer, G.,
and Schachner, M.
(1988)
J. Cell Biol.
106,
213-223 |
| 4. | Nagase, T., Nakamura, S., Harii, K., and Osumi, N. (2001) Dev. Growth Differ. 43, 683-692[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Jungalwala, F. B. (1994) Neurochem. Res. 19, 945-957[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Chou, D. K. H.,
Ilyas, A. A.,
Evans, J. E.,
Costello, C.,
Quarles, R. H.,
and Jungalwala, F. B.
(1986)
J. Biol. Chem.
261,
11717-11725 |
| 7. |
Voshol, H.,
van-Zuylen, C. W.,
Orberger, G.,
Vliegenthart, J. F.,
and Schachner, M.
(1996)
J. Biol. Chem.
271,
22957-22960 |
| 8. |
Terayama, K.,
Oka, S.,
Seiki, T.,
Miki, Y.,
Nakamura, A.,
Kozutsumi, Y.,
Takio, K.,
and Kawasaki, T.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
6093-6098 |
| 9. | Seiki, T., Oka, S., Terayama, K., Imiya, K., and Kawasaki, T. (1999) Biochem. Biophys. Res. Commun. 255, 182-187[CrossRef][Medline] [Order article via Infotrieve] |
| 10. |
Yamamoto, S.,
Oka, S.,
Saito-Ohara, F.,
Inazawa, J.,
and Kawasaki, T.
(2002)
J. Biochem.
131,
337-347 |
| 11. | Mitsumoto, Y., Oka, S., Sakuma, H., Inazawa, J., and Kawasaki, T. (2000) Genomics 65, 166-173[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Oka, S.,
Terayama, K.,
Kawashima, C.,
and Kawasaki, T.
(1992)
J. Biol. Chem.
267,
22711-22714 |
| 13. |
Terayama, K.,
Seiki, T.,
Nakamura, A.,
Matsumori, K.,
Ohta, S.,
Oka, S.,
Sugita, M.,
and Kawasaki, T.
(1998)
J. Biol. Chem.
273,
30295-30300 |
| 14. | Soriano, P., Montgomery, C., Geske, R., and Bradley, A. (1991) Cell 64, 693-702[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Yagi, T., Nada, S., Watanabe, N., Tamemoto, H., Kohmura, N., Ikawa, Y., and Aizawa, S. (1993) Anal. Biochem. 214, 77-86[CrossRef][Medline] [Order article via Infotrieve] |
| 16. |
Kuhn, R.,
Rajewsky, K.,
and Muller, W.
(1991)
Science
254,
707-710 |
| 17. | Morris, R. (1984) J. Neurosci. Methods 11, 47-60[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Miyamoto, M., Kiyota, Y., Yamazaki, N., Nagaoka, A., Matsuo, T., Nagawa, Y., and Takeda, T. (1986) Physiol. Behav. 38, 399-406[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Celio, M. R., and Blumcke, I. (1994) Brain Res. Brain Res. Rev. 19, 128-145[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Yoshihara, Y., Oka, S., Ikeda, J., and Mori, K. (1991) Neurosci. Res. 10, 83-105[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Muller, D., Wang, C., Skibo, G., Toni, N., Cremer, H., Calaora, V., Rougon, G., and Kiss, J. Z. (1996) Neuron 17, 413-422[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Nakamura, K., Manabe, T., Watanabe, M., Mamiya, T., Ichikawa, R., Kiyama, Y., Sanbo, M., Yagi, T., Inoue, Y., Nabeshima, T., Mori, H., and Mishina, M. (2001) Eur. J. Neurosci. 13, 179-189[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Saghatelyan, A. K., Dityatev, A., Schmidt, S., Schuster, T., Bartsch, U., and Schachner, M. (2001) Mol. Cell. Neurosci. 17, 226-240[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Cremer, H., Lange, R., Christoph, A., Plomann, M., Vopper, G., Roes, J., Brown, R., Baldwin, S., Kraemer, P., Scheff, S., Barthels, D., Rajewsky, K., and Wille, W. (1994) Nature 367, 455-459[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Mohan, P. S., Chou, D. K., and Jungalwala, F. B. (1990) J. Neurochem. 54, 2024-2031[CrossRef][Medline] [Order article via Infotrieve] |
| 26. |
Needham, L. K.,
and Schnaar, R. L.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
1359-1363 |
| 27. | Nair, S. M., and Jungalwala, F. B. (1997) J. Neurochem. 68, 1286-1297[Medline] [Order article via Infotrieve] |
| 28. | Miura, R., Ethell, I. M., and Yamaguchi, Y. (2001) J. Neurochem. 76, 413-424[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Saghatelyan, A. K., Gorissen, S., Albert, M., Hertlein, B., Schachner, M., and Dityatev, A. (2000) Eur. J. Neurosci. 12, 3331-3342[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
I. Morita, Y. Kizuka, S. Kakuda, and S. Oka Expression and Function of the HNK-1 Carbohydrate J. Biochem., June 1, 2008; 143(6): 719 - 724. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kizuka, K. Kobayashi, S. Kakuda, Y. Nakajima, S. Itoh, N. Kawasaki, and S. Oka Laminin-1 is a novel carrier glycoprotein for the nonsulfated HNK-1 epitope in mouse kidney Glycobiology, April 1, 2008; 18(4): 331 - 338. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yanagisawa and R. K Yu The expression and functions of glycoconjugates in neural stem cells Glycobiology, July 1, 2007; 17(7): 57R - 74R. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zuccato, N. Belyaev, P. Conforti, L. Ooi, M. Tartari, E. Papadimou, M. MacDonald, E. Fossale, S. Zeitlin, N. Buckley, et al. Widespread Disruption of Repressor Element-1 Silencing Transcription Factor/Neuron-Restrictive Silencer Factor Occupancy at Its Target Genes in Huntington's Disease J. Neurosci., June 27, 2007; 27(26): 6972 - 6983. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kizuka, T. Matsui, H. Takematsu, Y. Kozutsumi, T. Kawasaki, and S. Oka Physical and Functional Association of Glucuronyltransferases and Sulfotransferase Involved in HNK-1 Biosynthesis J. Biol. Chem., May 12, 2006; 281(19): 13644 - 13651. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tagawa, Y. Kizuka, T. Ikeda, S. Itoh, N. Kawasaki, H. Kurihara, M. L. Onozato, A. Tojo, T. Sakai, T. Kawasaki, et al. A Non-sulfated Form of the HNK-1 Carbohydrate Is Expressed in Mouse Kidney J. Biol. Chem., June 24, 2005; 280(25): 23876 - 23883. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kakuda, Y. Sato, Y. Tonoyama, S. Oka, and T. Kawasaki Different acceptor specificities of two glucuronyltransferases involved in the biosynthesis of HNK-1 carbohydrate Glycobiology, February 1, 2005; 15(2): 203 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kakuda, T. Shiba, M. Ishiguro, H. Tagawa, S. Oka, Y. Kajihara, T. Kawasaki, S. Wakatsuki, and R. Kato Structural Basis for Acceptor Substrate Recognition of a Human Glucuronyltransferase, GlcAT-P, an Enzyme Critical in the Biosynthesis of the Carbohydrate Epitope HNK-1 J. Biol. Chem., May 21, 2004; 279(21): 22693 - 22703. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Asano, S. Nakae, N. Kotani, N. Shirafuji, A. Nambu, N. Hashimoto, H. Kawashima, M. Hirose, M. Miyasaka, S. Takasaki, et al. Impaired selectin-ligand biosynthesis and reduced inflammatory responses in {beta}-1,4-galactosyltransferase-I-deficient mice Blood, September 1, 2003; 102(5): 1678 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kamiyama, T. Suda, R. Ueda, M. Suzuki, R. Okubo, N. Kikuchi, Y. Chiba, S. Goto, H. Toyoda, K. Saigo, et al. Molecular Cloning and Identification of 3'-Phosphoadenosine 5'-Phosphosulfate Transporter J. Biol. Chem., July 3, 2003; 278(28): 25958 - 25963. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okuda, T. Sawada, H. Nakano, K. Matsubara, Y. Matsuda, M. Fukuta, and O. Habuchi Mouse N-Acetylgalactosamine 4-Sulfotransferases-1 and -2. Molecular Cloning, Expression, Chromosomal Mapping and Detection of Their Activity with GalNAc{beta}1-4GlcNAc{beta}1-octyl J. Biochem., July 1, 2003; 134(1): 111 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-T. Kim, K. Tsuchida, J. Lincecum, H. Kitagawa, M. Bernfield, and K. Sugahara Identification and Characterization of Three Drosophila melanogaster Glucuronyltransferases Responsible for the Synthesis of the Conserved Glycosaminoglycan-Protein Linkage Region of Proteoglycans. TWO NOVEL HOMOLOGS EXHIBIT BROAD SPECIFICITY TOWARD OLIGOSACCHARIDES FROM PROTEOGLYCANS, GLYCOPROTEINS, AND GLYCOSPHINGOLIPIDS J. Biol. Chem., March 7, 2003; 278(11): 9116 - 9124. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Woodworth, D. Fiete, and J. U. Baenziger Spatial and Temporal Regulation of Tenascin-R Glycosylation in the Cerebellum J. Biol. Chem., December 20, 2002; 277(52): 50941 - 50947. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||